Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$12.83
+4.39%
Mkt Cap $865.14M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$39.00
Range $38.00 – $40.00
Implied Upside
+204.0%
Consensus $39.00 vs current $12.83
NASDAQ·Healthcare·Biotechnology
$12.83
+4.39%
Mkt Cap $865.14M
Buy
4
Hold
0
Sell
0
Price Target (6 analysts)
$39.00
Range $38.00 – $40.00
+204.0%
Consensus $39.00 vs current $12.83